Thomas O Daniel insider trades

Open-market stock purchases and sales by Thomas O Daniel, Director at Gossamer Bio, Inc, from SEC Form 4 filings since Mar 1, 2012.

Recent trades

DateStockTradeValue
Sep 23, 2026GOSS Gossamer Bio, IncBought (not open market)—
Jun 4, 2026GOSS Gossamer Bio, IncBought (not open market)—

Companies traded

  • GOSS Gossamer Bio, Inc: other filings, last Sep 23, 2026
  • MGTA Magenta Therapeutics, Inc: other filings, last Jun 28, 2022
  • LRMR Larimar Therapeutics, Inc: other filings, last May 12, 2021
  • ZFGN Zafgen, Inc: other filings, last Jun 26, 2019
  • JUNO Juno Therapeutics, Inc: other filings, last Mar 5, 2018
  • CELG Celgene Corp /de/: 8 sales, last Dec 17, 2015

Get free alerts when Thomas O Daniel files a new trade →